Xylia xylocarpa (Roxb) Taub. In Acne vulgaris Pharmaco- therapeutics approach

Xylia xylocarpa (Roxb) Taub. In yauvana pidaka (Acne vulgaris) Pharmaco- therapeutics approach - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085270

Enrollment

Registered

2025-04-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Shalmali Kantaka Sadrusha Pidaka Ghana Pidaka Medogarbha Pidaka Saruja Pidaka Non-inflammatory lesion with open and closed comedones Inflammatory lesion with papules, pustule, nodule and nodular cysts. Patients who meets diagnostic criteria with presence of acne only on the face.

Exclusion criteria

Exclusion criteria: Patients suffering from other systemic diseases which may interfere in course of study. Patients taking immune-suppressive medications. Lesions with secondary infections. Patients having other skin disorders or drug dependency. Pregnant and lactating women. Patients with major medical or surgical illness will be excluded from study.

Design outcomes

Primary

Measure	Time frame
To check and assess the following parameters Number of the papule/pustule Hardness of papule/pustule Pustule Size of the papule/pustule Swelling of papule/pustule pain in papule/pustule discoloration of papule/pustule pain in papule/pustule IGA Score GAGS Score Timepoint: 30 days	—

Secondary

Measure	Time frame
To reduce the chance of reoccurrence of Acne vulgarisTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Subrahmanya Padyana

Alvas Ayurveda Medical College and Hospital

drsp28@gmail.com9448327156

Outcome results